Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at PLCE's multiple
$0.0598.8% below market
0.94 ZNTL revenue / share×0.05x PLCE P/S=$0.05
Market $3.99Implied $0.05
PLCE · current priceP/S 0.05x
$2.81Latest market snapshot
Implied fair value · at ZNTL's multiple
$230.568,105.1% above market
54.36 PLCE revenue / share×4.24x ZNTL P/S=$230.56
Market $2.81Implied $230.56